Trial · NCT02600897
Participant flow63
How many started, completed or left each group, period by period.
61 to 63 of 63
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | NOT COMPLETED | Dose-escalation Phase: 1.8 mg Pola + 20 mg L + 375 mg R in DLBCL | 10 | |
| Overall Study | NOT COMPLETED | Expansion Phase: 1.4 mg Pola + 20 mg L + 1000 mg G in FL | 12 | |
| Overall Study | NOT COMPLETED | Expansion Phase: 1.8 mg Pola + 20 mg L + 375 mg R in DLBCL | 23 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02600897/flow?page=4